Passer au contenu principal
Centre intégré universitaire de santé
et de services sociaux de l'Est-de-l'Île-de-Montréal

Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal

Bernard Fortin

Bernard Fortin

Clinical Assistant Professor


Université de Montréal

Research Axes

Clinical research

Contact information

Dr. Fortin is a radiation oncologist at Hôpital Maisonneuve-Rosemont who specializes in head, neck, lung and thyroid cancers. He holds a master's in epidemiology and specializes in evaluative research and medical statistics training.

Research Unit

With his clinical research unit, he participates in various mucositis prevention protocols for head and neck cancers, altered fractionation protocols in lung cancer, research on the addition of immunotherapy to localized non-small cell lung cancer, research on the addition of immunotherapy to chemoradiotherapy in small cell lung cancer, and comparative research on the efficacy of radiation therapy for Graves’ orbitopathy.

With residents from various specialties (radiation oncology, oncology, respirology, dermatology), he teaches medical statistics and provides statistical consultation services for evaluative research projects carried out by residents and his colleagues.

Projects in 2020:

  • Evaluation of the efficacy of different adjuvant modalities for advanced endometrial cancers, with Valérie Dorion, radiation oncology resident at UdeM.
  • Prognostic factors for survival in patients with bullous pemphigoid, with Marco Cuarana and Patrick Cyr, medical students at UdeM, and Dr. Chantal Bolduc, a dermatologist at the CHUM.

Predictors of survival in patients with head and neck cancer and indeterminate lung nodules, with Vincent Côté-Provencher, a resident in radiation oncology at UdeM, and Dr. Houda Bahig, a radiation oncologist at the CHUM.

Statistical assistance for Dr. Michael Yassa, a radiation oncologist at the HMR for a Phase II protocol with the MUHC and JGH on radical radiation therapy with delayed or excluded surgery in localized breast cancer.

  • Marie-Hélène Ngo, et al. Abstract P4-12-07: Single pre-operative radiation therapy (SPORT) trial for low risk breast cancer: A phase 1 study comparing pathological findings in immediate versus delayed surgery, Conference Paper February 2020 Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas
  • Di Lalla, V., et al., Are radiation oncologists following guidelines? An audit of practice in patients with uncomplicated bone metastases. Technical Innovations & Patient Support in Radiation Oncology, 2019. 9: p. 13-17.
  • Pembroke, C.A., B. Fortin, and N. Kopek, Comparison of survival and prognostic factors in patients treated with stereotactic body radiotherapy for oligometastases or oligoprogression. Radiother Oncol, 2018.
  • Ibrahim, A., B. Fortin, and C. Boukaram, Frameless Stereotactic Radiosurgery with Linear Accelerator-Based Technology for Brain Metastases: Analysis of the Outcomes and Risk of Brain Radionecrosis in 141 Patients. Journal of Pain and Symptom Management, 2018. 56(6): p. e109-e110.